| Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS) (NCT04569435) | Annexon, Inc. | 2021-01-15 |
| Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer (NCT04683653) | University of Chicago | 2021-01-15 |
| An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine (NCT04713488) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2021-01-15 |
| Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke (NCT04675762) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-01-15 |
| An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease (NCT03770299) | Bristol-Myers Squibb | 2021-01-15 |
| Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome (NCT04622761) | The Clatterbridge Cancer Centre NHS Foundation Trust | 2021-01-15 |
| G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT (NCT04713956) | Nanfang Hospital, Southern Medical University | 2021-01-15 |
| A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC (NCT04699968) | Jiangsu HengRui Medicine Co., Ltd. | 2021-01-15 |
| Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC) (NCT04631601) | Amgen | 2021-01-15 |
| Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma (NCT04725214) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-01-15 |
| COVID-19 VACCINE SAFETY AND EFFECTIVENESS (NCT05133609) | Federal University of Espirito Santo | 2021-01-15 |
| Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases (NCT04789668) | M.D. Anderson Cancer Center | 2021-01-15 |
| 18F-fluoroestradiol (FES) PET/CT for Breast Cancer (NCT04883814) | Hoag Memorial Hospital Presbyterian | 2021-01-15 |
| Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia (NCT04714593) | Shanxi Province Cancer Hospital | 2021-01-15 |
| Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) (NCT04551495) | Jules Bordet Institute | 2021-01-14 |
| Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women (NCT04201821) | University of Pennsylvania | 2021-01-14 |
| Antibiotic Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty (NCT04135170) | The Norwegian Arthroplasty Register | 2021-01-14 |
| PEERS® for Italy, a Study on Social Skills Intervention for Adolescents With Autism Spectrum Disorder (ASD). (NCT05473104) | Istituto Superiore di Sanità | 2021-01-14 |
| CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS (NCT04668885) | Case Comprehensive Cancer Center | 2021-01-14 |
| Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis (NCT05906615) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-01-14 |
| Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19 (NCT04716998) | BonusBio Group Ltd | 2021-01-14 |
| Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (NCT04350190) | Wei Jiang | 2021-01-14 |
| Mepolizumab in Episodic Angioedema With Eosinophilia (NCT04128371) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-01-14 |
| Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy (NCT05052398) | Algenis SpA | 2021-01-14 |
| Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation (NCT04281498) | John Mascarenhas | 2021-01-14 |
| CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML (NCT04620681) | H. Lee Moffitt Cancer Center and Research Institute | 2021-01-14 |
| Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer (NCT04380545) | M.D. Anderson Cancer Center | 2021-01-13 |
| A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma (NCT05101356) | University of California, Davis | 2021-01-13 |
| Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma (NCT04737889) | Henan Cancer Hospital | 2021-01-13 |
| Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo (NCT04487860) | Ache Laboratorios Farmaceuticos S.A. | 2021-01-13 |
| Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients (NCT04310020) | National Cancer Institute (NCI) | 2021-01-13 |
| CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma (NCT04718883) | Shanghai Ming Ju Biotechnology Co., Ltd. | 2021-01-13 |
| A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response (NCT04632992) | Genentech, Inc. | 2021-01-13 |
| Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels (NCT04495608) | Hospices Civils de Lyon | 2021-01-13 |
| Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency (NCT04301765) | Seattle Institute for Biomedical and Clinical Research | 2021-01-12 |
| Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment (NCT04634071) | Joseph Valentino, MD | 2021-01-12 |
| DELP for Acute Hemorrhagic Stroke (NCT04708990) | General Hospital of Shenyang Military Region | 2021-01-12 |
| Tailored Sonidegib Schedule After Complete Response in BCC (NCT04806646) | Gruppo Oncologico del Nord-Ovest | 2021-01-12 |
| Open-label Trial of IVIG in Children With PANS (NCT04609761) | Göteborg University | 2021-01-12 |
| Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors (NCT04669899) | Jounce Therapeutics, Inc. | 2021-01-12 |
| Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients (NCT04428008) | William B. Ershler, MD | 2021-01-12 |
| Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis (NCT04175392) | Corewell Health East | 2021-01-12 |
| Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations (NCT04409639) | University of Utah | 2021-01-12 |
| Botulinum Toxin Type A for Foot Dystonia-associated Pain in Parkinson's Disease (NCT04277247) | University of Calgary | 2021-01-12 |
| A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function (NCT04628481) | Dompé Farmaceutici S.p.A | 2021-01-12 |
| Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia (NCT04466007) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2021-01-11 |
| High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients (NCT04613206) | Vanderbilt University Medical Center | 2021-01-11 |
| Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT) (NCT04706975) | Cara Therapeutics, Inc. | 2021-01-11 |
| Pregabalin Trial for the Treatment of Alcohol Use Disorder (NCT04322305) | New York State Psychiatric Institute | 2021-01-11 |
| Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer (NCT04172532) | National Cancer Institute (NCI) | 2021-01-11 |
| Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers (NCT04516135) | M.D. Anderson Cancer Center | 2021-01-11 |
| Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDS (NCT04429555) | MediciNova | 2021-01-11 |
| Efficacy of Bifidobacterium Lactis CCT 7858 in Adults Using Antibiotics (NCT04742322) | Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | 2021-01-11 |
| A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (NCT04569747) | Dana-Farber Cancer Institute | 2021-01-11 |
| Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19 (NCT04676867) | DalCor Pharmaceuticals | 2021-01-11 |
| Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma (NCT04589832) | Arkadiusz Z. Dudek, MD | 2021-01-11 |
| A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia (NCT04780841) | Ardelyx | 2021-01-11 |
| A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease (NCT04734197) | Surface Ophthalmics, Inc. | 2021-01-11 |
| Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection (NCT04705831) | IMMUNOe Research Centers | 2021-01-11 |
| Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperplasia (NCT04607252) | Fudan University | 2021-01-11 |
| Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations (NCT04579380) | Seagen, a wholly owned subsidiary of Pfizer | 2021-01-11 |
| Study of OLP-1002 Injections for Reducing Moderate to Severe Pain Due to Osteoarthritis in Hip and/or Knee Joint (NCT05216341) | OliPass Corporation | 2021-01-11 |
| MSC for Treatment of cGVHD After Allo-HSCT (NCT04692376) | Nanfang Hospital, Southern Medical University | 2021-01-10 |
| Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection (NCT04731116) | Rabin Medical Center | 2021-01-10 |
| Tislelizumab Combined With Sitravatinib as Consolidation Treatment Following Concurrent Chemoradiation in Patients With Locally Advanced, Unresectable NSCLC (NCT05176925) | Fudan University | 2021-01-10 |
| A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC) (NCT04728711) | Aldeyra Therapeutics, Inc. | 2021-01-09 |
| Regorafenib Plus Sintilimab vs. Regorafenib as the Second-line Treatment for HCC (NCT04718909) | Second Affiliated Hospital of Guangzhou Medical University | 2021-01-09 |
| Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer (NCT04842890) | The New York Proton Center | 2021-01-08 |
| Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19) (NCT04608214) | Assistance Publique - Hôpitaux de Paris | 2021-01-08 |
| Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography (NCT04338165) | University Hospital, Grenoble | 2021-01-08 |
| Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer (NCT04524000) | Novartis Pharmaceuticals | 2021-01-08 |
| Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B. (NCT04114890) | University of Oxford | 2021-01-08 |
| A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) (NCT04630145) | Janssen Pharmaceutical K.K. | 2021-01-08 |
| A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza (NCT04736758) | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 2021-01-08 |
| Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer (NCT04507841) | Tongji Hospital | 2021-01-08 |
| Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals (NCT04681430) | Heinrich-Heine University, Duesseldorf | 2021-01-08 |
| Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face (NCT04523961) | Mayo Clinic | 2021-01-08 |
| Study to AntagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19 (NCT04634799) | Northwestern University | 2021-01-08 |
| A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver Disease (NCT06256926) | COD Research Private Ltd | 2021-01-08 |
| Study of LL-BMT1 in Patients With Elevated Intraocular Pressure (NCT04747808) | MediPrint Ophthalmics, Inc. | 2021-01-08 |
| Study to Assess the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB®) Single Implantation in Tibial Fracture (NCT04432389) | Bone Therapeutics S.A | 2021-01-08 |
| Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma (NCT04150692) | Washington University School of Medicine | 2021-01-08 |
| Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC (NCT04865250) | University Hospital Heidelberg | 2021-01-07 |
| Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations (NCT04488003) | BioMed Valley Discoveries, Inc | 2021-01-07 |
| Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease (NCT04734210) | Surface Ophthalmics, Inc. | 2021-01-07 |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 (NCT04534205) | BioNTech SE | 2021-01-07 |
| A Study of TAK-919 in Healthy Japanese Adults (COVID-19) (NCT04677660) | Takeda | 2021-01-07 |
| Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy (NCT04532372) | City of Hope Medical Center | 2021-01-07 |
| Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma (NCT04601857) | Taiho Oncology, Inc. | 2021-01-07 |
| Lidocaine on Early Cognitive Dysfunction in Shoulder Arthroscopy (NCT04634656) | Assiut University | 2021-01-07 |
| Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis (NCT04438382) | ECOG-ACRIN Cancer Research Group | 2021-01-07 |
| Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC) (NCT04741165) | Taizhou Hanzhong biomedical co. LTD | 2021-01-07 |
| Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial (NCT04402788) | National Cancer Institute (NCI) | 2021-01-07 |
| A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults (NCT04668339) | Arcturus Therapeutics, Inc. | 2021-01-07 |
| Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant (NCT04322383) | National Cancer Institute (NCI) | 2021-01-07 |
| Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma：FDZL-GC001 Trial (NCT04510064) | Fudan University | 2021-01-06 |
| A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY (NCT04617275) | Pfizer | 2021-01-06 |
| Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers (NCT04903184) | RUTI Immunotherapeutics S.L. | 2021-01-06 |
| Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer (NCT04672005) | Lyudmyla Berim | 2021-01-06 |
| A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease (NCT04619420) | Janssen Research & Development, LLC | 2021-01-06 |